GNPX selects contract manufacturer for diabetes gene therapy scale-up
Genprex (GNPX) selected a leading clinical and commercial contract development and manufacturing organization to support manufacturing scale-up for its diabetes gene therapy; no deal size or timing was provided.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.